Skip to main content
Midas Edge

Amprius Technologies, Inc.

For the period ended Sep 30, 2025. Filed Nov 6, 2025.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2025 · Filed Nov 6, 2025

AMPX$9.17-3.7%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Condensed Consolidated Statements of Stockholders’ Equity

Common Stock · AdditionalPaid-inCapital · AccumulatedOther Comprehensive Loss · AccumulatedDeficit · TotalStockholders’Equity
(In thousands, except share data) · Shares · Amount
Balance as of December 31, 2024116,934,314$12$243,794$—$(174,334)$69,472
Issuance of common stock in connection with the At Market Issuance Sales Agreement, net of issuance cost2,585,646—8,429——8,429
Issuance of common stock upon exercise of stock options and vesting of restricted stock units1,026,117—48——48
Stock-based compensation——1,822——1,822
Net loss————(9,371)(9,371)
Other comprehensive loss———(4)—(4)
Balance as of March 31, 2025120,546,077$12$254,093$(4)$(183,705)$70,396
Issuance of common stock in connection with the At Market Issuance Sales Agreement, net of issuance cost3,175,85019,706——9,707
Issuance of common stock upon exercise of stock options and vesting of restricted stock units1,353,910—1,018——1,018
Stock-based compensation——1,906——1,906
Net loss————(6,370)(6,370)
Other comprehensive loss———(3)—(3)
Balance as of June 30, 2025125,075,837$13$266,723$(7)$(190,075)$76,654
Issuance of common stock in connection with the At Market Issuance Sales Agreement, net of issuance cost3,202,028—25,830——25,830
Issuance of common stock upon exercise of stock options and vesting of restricted stock units2,166,263—2,833——2,833
Stock-based compensation——1,763——1,763
Net loss————(3,892)(3,892)
Other comprehensive income———4—4
Balance as of September 30, 2025130,444,128$13$297,149$(3)$(193,967)$103,192
Common Stock · AdditionalPaid-inCapital · AccumulatedOther Comprehensive Loss · AccumulatedDeficit · TotalStockholders’Equity
(In thousands, except share data) · Shares · Amount
Balance as of December 31, 202388,869,463$9$189,454$—$(129,663)$59,800
Issuance of common stock in connection with the At Market Issuance Sales Agreement, net of issuance cost2,853,266—8,746——8,746
Issuance of common stock upon exercise of stock options and vesting of restricted stock units551,436—28——28
Stock-based compensation——1,247——1,247
Net loss————(9,886)(9,886)
Balance as of March 31, 202492,274,165$9$199,475—$(139,549)$59,935
Issuance of common stock in connection with the At Market Issuance Sales Agreement, net of issuance cost1,043,053—2,074——2,074
Issuance of common stock upon exercise of stock warrants, net of issuance cost13,075,664213,626——13,628
Issuance of common stock upon exercise of stock options and vesting of restricted stock units1,585,405—68——68
Stock-based compensation——1,941——1,941
Net loss————(12,517)(12,517)
Balance as of June 30, 2024107,978,287$11$217,184—$(152,066)$65,129
Issuance of common stock upon exchange of stock warrants for shares of common stock3,073,200—————
Issuance of common stock upon exercise of stock options and vesting of restricted stock units287,302—————
Stock-based compensation——1,720——1,720
Net loss————(10,850)(10,850)
Balance as of September 30, 2024111,338,789$11$218,904$—$(162,916)$55,999
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.